Key points A 75-year-old woman presented to the emergency department with acute confusion and lethargy on the third day of her first cycle of definitive radical chemoradiation for squamous cell ...

First-line zanidatamab plus chemotherapy leads to ‘practice-changing’ PFS and overall survival gains in a phase 3 study of ...

Future Pak becomes exclusive U.S. marketer for Mytesi® and Canalevia®-CA1 Meaningful non-dilutive capital enables Jaguar to ...

Rapid weight loss can increase gallstone formation, and hospitalists have reported more cases of biliary colic and ...

Dr. Erika Hamilton spoke with CURE’s editor-in-chief, Dr. Joshua K. Sabari.

Company achieved significant commercial progress in 2025, generating approximately $378 million in product revenue1 ...

DEAR DR. ROACH: After a month of testing from my gastrointestinal doctor, I have been diagnosed with irritable bowel syndrome (IBS). I have been sick for several months and have lost 12 pounds. (I’m ...

Company achieved significant commercial progress in 2025, generating approximately $378 million in product revenue1 IBSRELA achieved $274 million in revenue in 2025, representing 73% growth vs. 20241 ...

An emergency room physician describes why the 2025-26 flu season is hitting hard while doctor's visits for flu-like symptoms ...

The Philippine Red Cross on Saturday morning said it has attended to more than 800 patients at Traslacion 2026 in Manila ...

Even with breakthroughs, treatment for advanced squamous cell carcinoma is more complex. Patients often need more than one treatment. Many patients with this advanced cancer are cared for by a team of ...